License Agreement Cell Line

After the agreement is signed, you will receive 2 vials of frozen cells, a cell culture protocol and a test protocol to perform inhibition tests and you will have access to technical assistance from SOLVO staff. Harvard offers certain materials (usually organic research materials) for commercial use on a non-exclusive basis. Some materials, such as Z.B. Souris, are generally offered on a flat-rate basis or with fixed annual payments; others, such as hybrid cell lines, also include licensed payments. Typical agreements for both types of hardware licenses are listed below. This type of agreement allows Harvard researchers who are creating a new licensed business without difficulty to copyrighted non-patentable software that they have developed as part of the faculty`s research efforts. In cases where there are patentable topics such as unique algorithms, please read the „Exclusive Basic License“ agreement model published above. Contact your Account Manager for more information or to verify the draft licensing agreement. Notice of proposed third-party products – In the case of an exclusive license granted in all or in many areas, the licensee may first focus on a limited number of products or uses for the technology granted. In order to support Harvard`s mission to promote the common good by commercializing Harvard`s technology as widely as possible, Harvard may include provisions similar to those in the link below, to encourage a taker to develop third-party products or to sublicate the Harvard patent licensee`s rights to a third party to enable the development and commercialization of additional products. Global Access Note – The development of Technologies from Harvard Patents can lead to licensed products that could bring significant public health benefits in developing countries.

By participating in Universities Allied for Essential Medicines, Harvard is committed to promoting affordable access to these products in developing countries. To meet this obligation, we may require provisions similar to those in the link below in the exclusive licenses of this potentially effective technology. SOLVO Biotechnology offers the possibility of authorizing cell lines. Under the standard terms of a licensing agreement, you will receive the rights to use the cell line for ten years, free of charge (excluding CROs). You can opt for an annual maintenance fee for free cell replacement at any time. The criteria for accepting the performance of cell lines (for example. B signal-noise ratio) are included in the agreement. Cells that do not meet the criteria are replaced. ATCC recognizes the potential benefits of ATCC products in commercial applications. To meet these needs, ATCC has implemented an out-of-service licensing program that allows establishments to use ATCC products for commercial purposes as part of a non-exclusive licensing agreement. While ATCC views the Material Transfer Agreement (MTA) as an essential component of the distribution of its biological materials, the ATCC Commercial Use Licensing Program helps protect ATCC`s ability to provide research materials for the benefit of the scientific community.

According to the MTA ATCC, „commercial exploitation is the sale, license, leasing, export, transfer or distribution of organic materials to a person or organization that is not a party to this MTA, for financial or commercial purposes, and/or the use of biological material: (a) to provide a service to a person or organization that is not a party to that MTA, for financial gain; (b) to manufacture or manufacture products for general sale or manufacture of products for general sale; or (c) in relation to performance testing services, including, but not limited to service delivery, laboratory delivery, comparing and cancelling calibrations or tests performed on similar objects or materials